Hydrocortisone Acetate Suppository & Applicator
Treatment of acute flares in Ulcerative Colitis of the rectum (proctitis/proctosigmoiditis)
Phase 3Active
Key Facts
Indication
Treatment of acute flares in Ulcerative Colitis of the rectum (proctitis/proctosigmoiditis)
Phase
Phase 3
Status
Active
Company
About Cristcot
Cristcot is a strategic pharmaceutical development company founded in 2008, headquartered in Austin, Texas. It has built a pipeline based on patented drug formulation and delivery platforms, with a lead Phase 3-ready asset for ulcerative colitis of the rectum. The company operates with an integrated model encompassing clinical research, device engineering, and regulatory strategy, positioning itself to address significant gaps in gastroenterology disease management.
View full company profile